Izotropic Corporation (CSE:IZO)

Market Cap	20.60M
Revenue (ttm)	n/a
Net Income (ttm)	-2.31M
Shares Out	67.53M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,000
Average Volume	34,352
Open	0.3150
Previous Close	0.3050
Day's Range	0.3050 - 0.3150
52-Week Range	0.0350 - 0.4900
Beta	2.28
RSI	40.24
Earnings Date	Dec 30, 2025

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IZO